International BioPartnering Conference

Agenda | Speakers | Partnering | Presentations | Sponsors | Register

Conference Agenda

Monday, May 23, 2011

7:30 a.m. Registration Opens
8:00 – 8:45 a.m. Continental Breakfast in Exhibit Area
8:45 – 10:00 a.m.

Plenary Session: “Two Sides of the Deal”

Shiv Krishnan, Ph.D., Senior Director, Partnering and Innovation
sanofi-aventis US, Inc.

Kristin Mulready, Senior Manager, Alliance Management
ImmunoGen

Introduction by Campbell Alliance: Preview of “Dealmaker’s Intentions Survey”
Christopher Apolito, Senior Practice Executive
Campbell Alliance

10:00 – 10:15 a.m. Networking Break in the Exhibit Area
10:00 – 12:00 noon Ongoing 30-Minute Partnering Sessions
10:15 – 12:00 noon Ongoing 15-Minute Company Presentations
12:00 – 1:15 p.m.

Plenary Luncheon: “Exploring New Grounds for Pharma: Partnering on Innovation”

Morten Sorgaard, Ph.D., Executive Director & Head Biotechnology Unit, External R&D Innovation (ERDI)
Pfizer, Inc.

1:15 – 1:30 p.m. Networking Break in the Exhibit Area
1:30 – 3:00 p.m. Ongoing 30-Minute Partnering Sessions
1:30 – 3:00 p.m. Ongoing 15-Minute Company Presentations
3:00 – 4:00 p.m.

Panel Discussion: “Early Technology Deals”

Moderator
Zev Scherl, MBA, General Partner
New Spring Capital

Steve Carchedi, Chief Marketing Officer
GE Healthcare – Medical Diagnostics

Michael Cucolo, Director Technology Transactions, Strategic Transactions Group
Bristol-Myers Squibb Company

Tim Saxon, V.P. Business Development
Arecor

Scott Siegel, Vice President, Business Development
Ezose Sciences Inc.

4:00 – 5:00 p.m. Ongoing 30-Minute Partnering Sessions
4:00 – 5:00 p.m. Ongoing 15-Minute Company Presentations
5:00 – 6:00 p.m. Networking Cocktail Reception in the Exhibit Area
6:00 – 7:45 p.m.

Plenary Dinner & Keynote: “The Merck Model: Bringing our Passion for Science to Partnering”

David Nicholson, PhD, Senior Vice President and Head, Worldwide Licensing and Knowledge Management
Merck

7:45 – 9:00 p.m. Networking Dessert Reception in the Exhibit Area

Tuesday, May 24, 2011

8:00 – 8:30 a.m. Continental Breakfast in Exhibit Area
8:30 – 10:30 a.m.

Plenary Session
“Non-Dilutive Funding as a Step Toward Validation Panel”

Moderator
Brenda Gavin
, Founding Partner
Quaker BioVentures

Ram May-Ron, Managing Partner
FreeMind Group

Scott T. Megaffin, Senior Vice President, Commercial
Onconova Therapeutics Inc.

Richard Winneker, Ph.D., Senior Vice President, Research
The Leukemia & Lymphoma Society

“Investment Bankers Panel”

Luke Beshar, SVP & CFO
NPS Pharmaceuticals, Moderator

Chris Hite, Global Co-Head, Healthcare Investment Banking
Citigroup

Stephen A. Hurly, Managing Director
Boenning & Scattergood Inc.

John Leone, Partner
Paul Capital Healthcare

Graham A. Powis, Managing Director, Head of U.S. Equity Capital Markets
Lazard Frères & Co. LLC

10:30 – 10:45 a.m. Networking Break in the Exhibit Area
10:30 a.m. – 12:30 p.m. Ongoing 30-Minute Partnering Sessions
10:45 a.m. – 12:30 p.m. Ongoing 15-Minute Company Presentations
12:30 – 1:45 p.m.

Plenary Luncheon: “What Big Pharma Wants and What Biotech Can Deliver”

Steven J. Projan, Ph.D., FAAM, Sr. V.P. R&D
Innovative Medicines Head of Infectious Diseases & Vaccines
MedImmune

1:45 p.m. Meeting Adjourns

When we bring our global life sciences community together, we create the future.
Together. Forward.